Gritstone Oncology Inc (GRTS)
NASDAQ:GRTS
Holding GRTS?
Track your performance easily

Gritstone Oncology (GRTS) Financial Statements

815 Followers

Gritstone Oncology Financial Overview

Gritstone Oncology's market cap is currently ―. The company's EPS TTM is $-1.153; its P/E ratio is -0.48; Gritstone Oncology is scheduled to report earnings on November 7, 2024, and the estimated EPS forecast is $-0.19. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 921.00K$ 1.74M$ 29.00K$ 1.56M$ 1.96M
Gross Profit$ 921.00K$ 1.74M$ 10.38M$ 1.56M$ 1.96M
EBIT$ -22.09M$ -39.09M$ -29.60M$ -37.44M$ -34.27M
EBITDA$ -20.03M$ -37.03M$ -27.68M$ -35.77M$ -32.89M
Net Income Common Stockholders$ -23.40M$ -40.38M$ -30.82M$ -38.43M$ -35.26M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 55.71M$ 46.30M$ 79.29M$ 83.95M$ 116.97M
Total Assets$ 142.54M$ 137.21M$ 177.77M$ 187.22M$ 222.62M
Total Debt$ 102.49M$ 103.28M$ 104.78M$ 95.30M$ 95.39M
Net Debt$ 46.78M$ 56.98M$ 25.49M$ 11.35M$ -21.59M
Total Liabilities$ 120.35M$ 123.25M$ 125.92M$ 113.23M$ 113.06M
Stockholders Equity$ 22.19M$ 13.96M$ 51.85M$ 73.98M$ 109.58M
Cash Flow-
Free Cash Flow$ -26.84M$ -33.71M$ -19.70M$ -32.18M$ -32.68M
Operating Cash Flow$ -26.81M$ -33.57M$ -19.51M$ -31.09M$ -30.96M
Investing Cash Flow$ -885.00K$ 12.30M$ 38.30M$ 18.28M$ 24.59M
Financing Cash Flow$ 35.63M$ -379.00K$ 15.72M$ -264.00K$ 1.02M
Currency in USD

Gritstone Oncology Earnings and Revenue History

Gritstone Oncology Debt to Assets

Gritstone Oncology Cash Flow

Gritstone Oncology Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis